Download A4Medicine Mobile App
Empower Your RCGP AKT Journey: Master the MCQs with Us! 🚀
Loss of libido (↓ sexual desire) is a common but often hidden concern in primary care. It refers to a persistent or recurrent reduction in sexual interest that causes personal distress or relationship difficulties.
Although medically defined within DSM-5 as:
Hypoactive Sexual Desire Disorder (HSDD) – in men
Female Sexual Interest/Arousal Disorder (FSIAD) – in women
...GPs typically use the broader, patient-friendly term “low libido.”
Common: ~15% of men, 34% of women (16–74 yrs) report ↓ interest in sex (Natsal-3, 2013) [1].
Under-discussed: Many affected patients never raise it—GPs must be ready to ask sensitively.
Multifactorial Causes:
Biological: Endocrine disorders, chronic illness, medications
Psychological: Depression, anxiety, past trauma
Social: Relationship issues, cultural beliefs
Category | Males | Females |
---|---|---|
Biological |
↓ Testosterone (e.g. hypogonadism) Chronic illness (DM, CVD) Medication (SSRIs, β-blockers) Obesity Thyroid dysfunction |
Hormonal changes (↓ estrogen, menopause, postpartum) Chronic illness (DM, CVD) Medication (SSRIs, OCPs) Thyroid dysfunction Pregnancy, breastfeeding |
Psychological |
Stress, anxiety Depression Low self-esteem, poor body image Relationship issues Performance anxiety |
Stress, anxiety Depression Low self-esteem, poor body image Relationship issues Trauma or abuse history |
Social/Cultural |
Masculinity pressures Work-life imbalance Cultural/religious beliefs Aging concerns |
Body image pressures Work-life imbalance Cultural/religious beliefs Life transitions (motherhood, menopause) |
Causes often overlap, but sex-specific hormonal & life-stage factors are distinct. Holistic assessment is key to identifying contributing factors.
Clarify the Symptom
Ask what the patient means by "loss of libido" (e.g., reduced desire, arousal issues, or performance difficulties).
Differentiate between loss of desire (will) and sexual dysfunction (e.g., erectile dysfunction, dyspareunia).
Ask: “Is this issue present in all situations (e.g., with a partner or alone) or specific contexts?”
Explore terminology used by the patient, considering cultural or personal language preferences.
Onset and Duration
Ask: “When did you first notice a change in your sexual desire? Was it sudden or gradual?”
Determine if symptoms are progressive, intermittent, or related to specific times (e.g., worse at night).
Explore potential triggers: “Did anything specific happen around the time this started, like a life event or new medication?”
Relationship Context
Assess relationship quality: “How would you describe your relationship with your partner(s)?”
Ask: “Did relationship issues or loss of libido come first?”
Explore partner dynamics: “Have you discussed this with your partner? What is their perspective?”
For single patients: “Has this affected your interest in pursuing sexual activity?”
Include: “What is your sexual orientation or relationship structure (e.g., monogamous, non-monogamous)?”
Patient’s Perception and Concerns
Ask: “How does this change in libido affect you? Is it distressing, or is it more about meeting partner expectations?”
Determine who initiated the consultation: “Did you or your partner feel this needed to be addressed?”
Explore cultural expectations: “Do you feel pressure to maintain a certain level of sexual activity?”
Assess impact: “Does this affect your self-esteem or sense of identity?”
Health and Medications
Review general health: chronic illnesses (e.g., diabetes, thyroid disease, cancer), recent acute illnesses, or surgeries (e.g., pelvic surgery, chemotherapy).
Document medications, including SSRIs, beta-blockers, hormonal contraceptives, anti-androgens, and over-the-counter supplements.
Ask: “Have you started or stopped any medications or supplements recently?”
Psychological Factors
Screen for depression/anxiety using PHQ-2: “Over the past two weeks, have you felt down, depressed, or hopeless? Have you had little interest in doing things?”
Explore trauma sensitively: “Have you experienced events that make sexual activity difficult?”
Assess body image: “Do you feel confident in your body, or has this changed recently?”
Lifestyle Factors
Quantify alcohol (units/week), smoking, and recreational drug use.
Ask about stress: “Are you experiencing pressures from work, finances, or family?”
Explore sleep and fatigue: “Do you feel well-rested, or are you often tired?”
Assess exercise: “How active are you, and has this changed recently?”
Reproductive History
For women: Ask about menopause, menstrual cycle changes, contraception, pregnancy, childbirth, or breastfeeding.
For men: Explore hypogonadism symptoms (e.g., “Have you noticed changes in energy, muscle mass, or body hair?”).
Ask both: “Are you concerned about fertility or undergoing fertility treatments?”
Sexual History Specifics
Ask: “How often do you engage in sexual activity, and has this changed?”
Explore satisfaction: “Are you satisfied with your sexual experiences?”
Assess solo activity: “Has your interest in masturbation or solo sexual activity changed?”
Inquire about safe sex, STI history, or pornography use if relevant.
Patient’s Insight
Ask: “What do you think is the reason for your loss of sexual drive?”
Explore barriers: “Are there challenges, like embarrassment or lack of information, that make addressing this difficult?”
Consider cultural/religious beliefs: “Do any personal or cultural values affect how you view this issue?”
Safeguarding
Screen sensitively: “Do you feel safe and comfortable in your sexual relationships?”
Be alert for signs of intimate partner violence or coercion.
This structured, holistic approach ensures a comprehensive assessment of loss of libido, addressing biological, psychological, and social factors as per RCGP curriculum guidance. It supports culturally sensitive, patient-centered care and facilitates tailored management.
When a patient presents with loss of libido (LOL), primary care clinicians should adopt a targeted, stepwise approach to investigations, guided by clinical history, examination, and risk factors.
Practical Notes for Primary Care:
Prioritization: Start with FBC, TFTs, HbA1c, lipids to identify common reversible causes.
Timing: For testosterone in men, sample in the morning before 11 AM (avoids diurnal variation).
Cost-Effectiveness: Avoid routine prolactin unless symptoms suggest pituitary dysfunction.
Referral Threshold: Refer to endocrinology, sexual health clinics, or psychosexual counselling if initial workup is normal or complex issues arise.
Patient Communication: Explain the rationale to reduce stigma and support follow-up, aligned with RCGP patient-centered care principles.
This structured approach ensures cost-effective, evidence-based assessment in line with UK guidelines and the RCGP curriculum.
Test | Purpose | When to Order | Gender |
---|---|---|---|
Full Blood Count (FBC) | Detect anaemia, chronic illness | Fatigue, pallor, systemic illness | Both |
Thyroid Function Tests (TFTs) | Assess hypo ↑ / hyper ↓ thyroidism | Lethargy, weight changes, menstrual issues | Both |
HbA1c / Fasting Glucose | Screen for diabetes | Obesity, polyuria, FHx of diabetes | Both |
Lipid Profile | Evaluate cardiovascular risk | Hypertension, smoking, erectile dysfunction | Both |
Liver Function Tests (LFTs) | Detect liver dysfunction | Alcohol excess, jaundice | Both |
Serum Ferritin / Iron Studies | Check for iron deficiency ↓ or overload ↑ | Fatigue, anaemia on FBC | Both |
Total Testosterone | Screen for hypogonadism | Low energy, ED, ↓ muscle mass | Male |
SHBG (Sex Hormone Binding Globulin) | Calculate free testosterone | Borderline testosterone, obesity | Male (± Female) |
Prolactin | Identify hyperprolactinaemia | Galactorrhoea, irregular menses, antipsychotic use | Both |
FSH / LH / Estradiol | Assess ovarian function, menopause | Irregular periods, menopausal symptoms | Female |
Androgens (FAI, etc.) | Evaluate androgen insufficiency ↓ | PCOS, hirsutism, post-menopause | Female |
Aligned with RCGP curriculum, BSSM (2018), and NICE guidelines, management of LOL in UK primary care uses a biopsychosocial, patient-centered approach.
Principle | Strategies | Key Guidelines/Notes |
---|---|---|
Holistic Assessment |
- Explore biological, psychological, social factors - Use shared decision-making - Respect cultural beliefs |
RCGP, Natsal-3 (2013) |
Treat Reversible Causes |
- Manage hormonal imbalances (e.g., TRT for men, HRT for women) - Optimize chronic disease care - Review medications |
BSSM 2018, NICE NG23 (2015) |
Psychological Support |
- Screen for depression/anxiety (PHQ-9, GAD-7) - Refer to IAPT or counselling - Encourage CBT, mindfulness |
NICE CG90 (2009) |
Relationship & Social Factors |
- Provide relationship counselling - Refer for psychosexual therapy - Address social stressors |
Natsal-3 (2013), COSRT |
Lifestyle Changes |
- Promote healthy weight, exercise, ↓ alcohol, smoking cessation - Improve sleep hygiene |
BSSM 2018, NICE 2020 |
Pharmacological Options |
- PDE-5 inhibitors for ED - Testosterone for postmenopausal women (off-label, specialist-led) - Avoid unproven treatments |
NICE CKS 2021, BSSM 2018 |
Specialist Referral | - Endocrinology, sexual health, psychiatry, gynaecology when indicated | RCGP 2020 |
Education & Empowerment |
- Explain test results & treatment rationale - Signpost reputable information sources - Encourage partner communication |
Natsal-3 (2013), NHS resources |
Safeguarding & Ethics |
- Screen for domestic abuse - Maintain confidentiality - Respect patient autonomy |
RCGP, GMC guidelines |
Follow-Up |
- Review in 4–6 weeks - Use patient-reported outcomes - Adjust care plan or refer |
RCGP: Continuity of care principle |
By addressing loss of libido - with empathy, thorough assessment, and tailored interventions, GPs can improve patients’ quality of life, relationships, and overall well-being, aligning with the RCGP’s commitment to holistic, equitable care.
References and Citations
Mercer, C. H., et al. (2013). Sexual function in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). The Lancet, 382(9907), 1817–1829.
British Society for Sexual Medicine (BSSM). (2018). Guidelines on the Management of Sexual Problems in Men and Women.
National Institute for Health and Care Excellence (NICE). (2015). Guideline NG23: Menopause – Diagnosis and Management. Available here: https://www.nice.org.uk/guidance/ng23
NICE Clinical Knowledge Summaries (CKS). (2021). Erectile Dysfunction. Available here: https://cks.nice.org.uk/topics/erectile-dysfunction
NICE. (2009, updated 2011). Guideline CG90/CG91: Depression in Adults – Recognition and Management. Available here: https://www.nice.org.uk/guidance/cg90
Royal College of General Practitioners (RCGP). (2020). Curriculum: Sexual Health. Available here: https://www.rcgp.org.uk/getmedia/4b80030b-5994-4299-9f4e-a2a0b07469f1/Sexual-Health-SCCG-2025.pdf
Byrne, M., et al. (2015). Discussing sexual dysfunction with patients in primary care: a qualitative study. BMJ Open, 5(11), e008779.
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5).
Patient.info. Loss of Libido: Causes and Treatment. Available here: https://patient.info/doctor/loss-of-libido
NHS UK. Loss of Libido. Available here: https://www.nhs.uk/symptoms/loss-of-libido
Royal Australian College of General Practitioners (RACGP). (2023). Male Sexual Dysfunction: Clinical Diagnosis. Available here: https://www1.racgp.org.au/ajgp/2023/january-february/male-sexual-dysfunction
Royal United Hospitals Bath NHS Foundation Trust (RUH NHS). Primary Care Management of Erectile Dysfunction. Available here: https://www.ruh.nhs.uk/For_Clinicians/departments_ruh/Urology/documents/Primary_Care_Management_of_Erectile_Dysfunction.pdf
Northern Lincolnshire NHS. (2024). Amber 1 Guidance: Topical Testosterone for Low Libido in Women. Available here: https://www.northernlincolnshireapc.nhs.uk/wp-content/uploads/2024/10/Amber%201%20guidance%20testosterone%20for%20low%20libido.pdf?_t=1728310649&UNLID=9747740192025416926
European Association of Urology (EAU). Guidelines on Sexual and Reproductive Health - Male Hypogonadism. Available here: https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/male-hypogonadism